Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Maryland St. Joseph Medical Center
About this trial
Spinal Cord Stimulation using 10 kHz stimulation to the thoracic spinal cord will be a safe and effective treatment for CIPN, reducing pain in the lower extremities by at least 50%.
Eligibility criteria
Qualifiers
CIPN as diagnosed by Oncology and/or neurology
Receipt of a platinum-based or taxane chemotherapy prior to development of CIPN
Pain severity greater than 4 out of 10 on a numeric rating scale of pain
Pain chronicity greater than 6 months after the cessation of chemotherapy
Disqualifiers
Platelet count less than 100k/mm3
Spinal anatomy precluding placement of the SCS leads between T6 and T11
Active infection
Estimated Lifespan less than 1 year
Trial design
Treatments tested in this trial
- Spinal Cord Stimulation Implant
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov